NovaBridge Biosciences: common_shares_outstanding
| Value | {"unit": "shares", "value": 265377891, "concept": "dei:EntityCommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d76d1eb7-6e37-4d0b-8ea3-0b93c26bd457
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001778016-26-000006Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/common-shares-outstanding/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d76d1eb7-6e37-4d0b-8ea3-0b93c26bd457
History
- supersedes {"unit": "shares", "value": 265377891, "concept": "us-gaap:CommonStockSharesOutstanding"} (evidence 0001778016-26-000002)